©The Author(s) 2025.
World J Gastroenterol. Oct 28, 2025; 31(40): 111727
Published online Oct 28, 2025. doi: 10.3748/wjg.v31.i40.111727
Published online Oct 28, 2025. doi: 10.3748/wjg.v31.i40.111727
Figure 2 Trend of GALAD score across healthy individuals, patients with compensated cirrhosis and hepatocellular carcinoma.
HCC: Hepatocellular carcinoma; CLD: Chronic liver disease.
- Citation: Villa E, Donghia R, Coletta S, Bonfiglio C, Critelli RM, Ancona A, Shahini E, Iacovazzi PA, Cozzolongo R, Pavone F, Carella N, Pontisso P, Martini A, Al Aoua S, Bantel H, Giannelli G. Insights into the GALAD score: A new optimal cut-off for hepatocellular carcinoma. World J Gastroenterol 2025; 31(40): 111727
- URL: https://www.wjgnet.com/1007-9327/full/v31/i40/111727.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i40.111727